The Journal of Heart and Lung Transplantation
Volume 27, Issue 7 , Pages 722-728 , July 2008

C3d and C4d Deposition Early After Lung Transplantation

  • Glen P. Westall, MD

      Affiliations

    • Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Monash University Medical School, Melbourne, Victoria, Australia
    • Corresponding Author InformationReprint requests: Glen Westall, MD, Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital, Commercial Road, Prahran, VIC 3181, Australia. Telephone: +61-3-9076-2405. Fax: +61-3-9076-3601.
    • ,
  • Greg I. Snell, MD

      Affiliations

    • Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Monash University Medical School, Melbourne, Victoria, Australia
    • ,
  • Catriona McLean, MD

      Affiliations

    • Department of Pathology, Alfred Hospital and Monash University Medical School, Melbourne, Victoria, Australia
    • ,
  • Tom Kotsimbos, MD

      Affiliations

    • Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Monash University Medical School, Melbourne, Victoria, Australia
    • ,
  • Trevor Williams, MD

      Affiliations

    • Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Monash University Medical School, Melbourne, Victoria, Australia
    • ,
  • Cynthia Magro, MD

      Affiliations

    • Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, New York.

Received 6 January 2008 ,Revised 6 January 2008 ,Accepted 27 March 2008.

References 

  1. Bos I, Ten Berge I, Hack C. Role of complement in graft rejection after organ transplantation. Transfus Med Rev. 2002;16:251–264
  2. Feucht H, Felber E, Gokel M, et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol. 1991;86:464–470
  3. Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch M. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol. 2002;13:242–251
  4. Smith R, Brousaides N, Grazette L, et al. C4d deposition in cardiac allografts correlates with alloantibody. J Heart Lung Transplant. 2005;24:1202–1210
  5. Turner M. Mannose-binding lectin (MBL) in health and disease. Immunobiology. 1998;199:327–339
  6. Worthley D, Bardy P, Mullighan C. Mannose-binding lectin: biology and clinical implications. Int Med J. 2005;35:548–555
  7. Eisen D, Minchinton R. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis. 2003;37:1496–1505
  8. Bouwman L, Roos A, Terpstra O, et al. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology. 2005;129:408–414
  9. de Vries B, Walter S, Peutz-Kootstra C, et al. The mannose-binding lectin pathway is involved in complement activation in the course of renal ischemia–reperfusion injury. Am J Pathol. 2004;165:1677–1688
  10. Magro C, Abbas A, Seilstad K, et al. C3d and the septal microvasculature as a predictor of chronic lung allograft dysfunction. Hum Immunol. 2006;67:274–283
  11. Magro C, Deng A, Pope-Harman A, et al. Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis. Transplantation. 2002;74:1273–1280
  12. Magro C, Klinger D, Adams P, et al. Evidence that humoral allograft rejection in lung transplant patients is not histocompatibility antigen-related. Am J Transplant. 2003;3:1264–1272
  13. Magro C, Pope Harman A, Klinger D, et al. Use of C4d as a diagnostic adjunct in lung allograft biopsies. Am J Transplant. 2003;3:1143–1154
  14. Magro C, Ross P, Kelsey M, Waldman W, Pope-Harman A. Association of humoral immunity and bronchiolitis obliterans syndrome. Am J Transplant. 2003;3:1155–1166
  15. Badesch D, Zamora M, Fullerton D, et al. Pulmonary capillaritis: a possible histologic form of acute pulmonary allograft rejection. J Heart Lung Transplant. 1998;17:415–422
  16. Saint Martin G, Reddy V, Garrity E, et al. Humoral (antibody-mediated) rejection in lung transplantation. J Heart Lung Transplant. 1996;15:1217–1222
  17. Astor T, Weill D, Cool C, Teitelbaum I, Schwarz M, Zamora M. Pulmonary capillaritis in lung transplant recipients: treatment and effect on allograft function. J Heart Lung Transplant. 2005;24:2091–2097
  18. Miller G, Destarac L, Zeevi A, et al. Acute humoral rejection of human lung allografts and elevation of C4d in bronchoalveolar lavage fluid. Am J Transplant. 2004;4:1323–1330
  19. Wallace W, Reed E, Ross D, Lassman C, Fishbein M. C4d staining of pulmonary allograft biopsies: an immunoperoxidase study. J Heart Lung Transplant. 2005;24:1565–1570
  20. Ionescue D, Girnita A, Zeevi A, et al. C4d deposition in lung allografts is associated with circulating anti-HLA antibody. Transplant Immunol. 2005;15:63–68
  21. Oto T, Griffiths A, Rosenfeldt F, Levvey B, Williams T, Snell G. Early outcomes comparing Perfadex, Euro-Collins, and Papworth solutions in lung transplantation. Ann Thorac Surg. 2006;82:1842–1848
  22. Christie J, Carby M, Bag R, et al. Report of the ISHLT working group on primary lung graft dysfunction (Part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation). J Heart Lung Transplant. 2005;24:1454–1459
  23. Yousem S, Berry G, Cagle P, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection. J Heart Lung Transplant. 1996;15:1–15
  24. Estenne M, Maurer J, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant. 2002;21:297–310
  25. Magro C, Calomeni E, Nadasdy T, et al. Ultrastructure as a diagnostic adjunct in the evaluation of lung allograft biopsies. Ultrastruct Pathol. 2005;29:95–106
  26. Garred P, Madsen H, Hofmann B, Svejgaard A. Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet. 1995;346:941–943
  27. Garred P, Pressler T, Madsen H, et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest. 1999;104:431–437
  28. Naka Y, Marsh H, Scesney S, Oz M, Pinsky D. Complement activation as a cause for primary graft failure in an isogeneic rat model of hypothermic lung preservation and transplantation. Transplantation. 1997;64:1248–1255
  29. Bishop M, Giclas P, Guidotti S, Su M, Chi E. Complement activation is a secondary rather than a causative factor in rabbit pulmonary artery ischemia/reperfusion injury. Am Rev Respir Dis. 1991;143:386–390
  30. Haccuria A, Knoop C, Magro C, et al. Primary graft dysfunction (PGD) after lung transplantation: acute humoral rejection may play a causative role. J Heart Lung Transplant. 2006;25(suppl):S185
  31. Keshavjee S, Davis R, Zamora M, de Perrot M, Patterson G. A randomized, placebo-controlled trial of complement inhibition in ischemia–reperfusion injury after lung transplantation in human beings. J Thorac Cardiovasc Surg. 2005;129:423–428

PII: S1053-2498(08)00280-5

doi: 10.1016/j.healun.2008.03.018

The Journal of Heart and Lung Transplantation
Volume 27, Issue 7 , Pages 722-728 , July 2008

Article Tools

* Image Usage & Resolution